Opticyte
Seattle, US · Founded 2016 · 9 employees on LinkedIn · 1 known investors
Find your way into Opticyte
108 people in our graph share verified history with the Opticyte team — schools, employers, funds. One of them is your warm intro.
Paul Jennyunlockedknows Lori Arakaki · together at University of Washington (overlapped)
×4knows the team · via University of Pennsylvania
×2knows the team · via Women Business Leaders of the US Health Care Industry Foundation (WBL)
×5knows the team · via University of Washington
Opticyte develops the VitalO₂, a preclinical-stage medical device aimed at hospitals, with an FDA De Novo pathway and Breakthrough Device Designation. The company operates in the medical device sector.
Founders & leadership
Opticyte was founded in 2016 by Lori Arakaki.
LA
Lori ArakakiinFounder · Chief Executive OfficerLori Arakaki is the founder of Opticyte and has a background in bioengineering, with research expertise in developing algorithms for measuring component concentrations in biological optical spectra.
RM
Robert MastersonNamed on SEC filing
KS
Kenneth SchenkmanNamed on SEC filing
LA
Lorilee ArakakiNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$72.3K disclosed across 1 round · 2017
▶$72.3KraisedOct 2017 · 2 investors · BiotechnologyRule 506(b)
▶$72.3KraisedOct 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert MastersonExecutive Officer, Director, Promoter
- Kenneth SchenkmanExecutive Officer, Director, Promoter
- Lorilee ArakakiExecutive Officer, Director, Promoter
- Offering amount
- $2.3M
- Amount sold
- $72.3K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Rf Surgical4 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Triple Ring Technologies3 shared keywords
Companies competing with Opticyte for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Opticyte do?
- Opticyte develops the VitalO₂, a preclinical-stage medical device aimed at hospitals, with an FDA De Novo pathway and Breakthrough Device Designation. The company operates in the medical device sector.
- Who founded Opticyte?
- Opticyte was founded by Lori Arakaki in 2016.
- Who are Opticyte's investors?
- Opticyte's investors include Swan Venture Fund.
- How much funding has Opticyte raised?
- Opticyte has disclosed $72.3K raised across 1 round.
- Where is Opticyte headquartered?
- Opticyte is headquartered in Seattle, US.